We hereby submit certificate under regulation 74(5) of SEBI (DP) Regulations, 2018 for the Quarter ended March 31, 2026.

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+44.0%1-day move

₹171.20

prior close

₹205.40

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-2.6+0.0-0.2+0.0+44.0+58.3+66.2+74.5+83.2+102.0+84.3+49.8+20.9+4.3

Up moveDown movePending

AI summary

Speciality Medicines Ltd has submitted a compliance certificate confirming that no physical share certificates were received for dematerialization during Q4 FY2025-26 (January-March 2026). The certificate was issued by Skyline Financial Services Private Limited, the company's Registrar and Share Transfer Agent (RTA), as required under SEBI regulations. This is a routine regulatory filing confirming the smooth functioning of the dematerialization process. The company trades on BSE with code 544738 and was formerly known as Speciality Medicines Private Limited.

Likely market impact

This is a routine compliance filing with no direct impact on the company's financial position or stock price. It simply confirms that the share dematerialization process is functioning normally with no issues to report.